41
Participants
Start Date
May 11, 2023
Primary Completion Date
September 25, 2024
Study Completion Date
September 25, 2024
Danavorexton
Danavorexton IV infusion.
Placebo
Placebo matching danavorexton IV infusion.
Medical Research Center - Clinic/Outpatient Facility, Miami
Rush University, Chicago
Cedars Sinai Medical Hospital, West Hollywood
Helen Keller Hospital, Sheffield
Mayo Clinic - PPDS - Hospital, Phoenix
UCSD, La Jolla
Mayo Clinic Jacksonville - PPDS, Jacksonville
University of Miami - Leonard M. Miller School of Medicine, Miami
University of South Florida, Tampa
Cleveland Clinic Florida, Weston
University of Louisville - Hospital, Louisville
Brigham and Womens Hospital, Boston
Inspira Health, Mullica Hill
NYU Langone, Mineola
Stony Brook University Medical Center, Stony Brook
Fairview Hospital, Cleveland
Cleveland Clinic Hospital, Cleveland
Ohio State University Wexner Medical Center, Columbus
The Medical College of Wisconsin, Inc., Milwaukee
Lead Sponsor
Takeda
INDUSTRY